Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 7904 | 2017 |
Circulating microRNAs in patients with coronary artery disease S Fichtlscherer, S De Rosa, H Fox, T Schwietz, A Fischer, C Liebetrau, ... Circulation research 107 (5), 677-684, 2010 | 1495 | 2010 |
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ... European heart journal 41 (22), 2083-2088, 2020 | 1036 | 2020 |
Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links S De Rosa, B Arcidiacono, E Chiefari, A Brunetti, C Indolfi, DP Foti Frontiers in endocrinology 9, 334630, 2018 | 356 | 2018 |
Transcoronary concentration gradients of circulating microRNAs S De Rosa, S Fichtlscherer, R Lehmann, B Assmus, S Dimmeler, ... Circulation 124 (18), 1936-1944, 2011 | 323 | 2011 |
Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 313 | 2019 |
Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature D Erkapic, S De Rosa, A Kelava, R Lehmann, S Fichtlscherer, ... Journal of cardiovascular electrophysiology 23 (4), 391-397, 2012 | 285 | 2012 |
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation P Cirillo, P Golino, P Calabro, G Calì, M Ragni, S De Rosa, G Cimmino, ... Cardiovascular research 68 (1), 47-55, 2005 | 218 | 2005 |
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ... European heart journal 43 (7), e17-e25, 2022 | 191 | 2022 |
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR NM Van Mieghem, M Unverdorben, C Hengstenberg, H Moellmann, ... New England Journal of Medicine 385 (23), 2150-2160, 2021 | 183 | 2021 |
Patient selection and timing of continuous renal replacement therapy M Ostermann, M Joannidis, A Pani, M Floris, S De Rosa, JA Kellum, ... Blood purification 42 (3), 224-237, 2016 | 170 | 2016 |
MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis C Eyileten, Z Wicik, S De Rosa, D Mirowska-Guzel, A Soplinska, C Indolfi, ... Cells 7 (12), 249, 2018 | 155 | 2018 |
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik, C Eyileten, S De Rosa, ... Cardiovascular diabetology 18, 1-19, 2019 | 136 | 2019 |
Emerging role of microRNAs in cardiovascular diseases S De Rosa, A Curcio, C Indolfi Circulation Journal 78 (3), 567-575, 2014 | 128 | 2014 |
MicroRNAs for restenosis and thrombosis after vascular injury C Gareri, S De Rosa, C Indolfi Circulation research 118 (7), 1170-1184, 2016 | 126 | 2016 |
Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis J Sabatino, S De Rosa, G Di Salvo, C Indolfi PloS one 15 (8), e0237131, 2020 | 124 | 2020 |
The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no … K Hemmann, M Sirotina, S De Rosa, JR Ehrlich, H Fox, J Weber, A Moritz, ... Interactive cardiovascular and thoracic surgery 17 (2), 359-364, 2013 | 118 | 2013 |
Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: primary results of the international multicenter iFR … Y Kikuta, CM Cook, ASP Sharp, P Salinas, Y Kawase, Y Shiono, ... JACC: Cardiovascular interventions 11 (8), 757-767, 2018 | 116 | 2018 |
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study L De Luca, S Leonardi, C Cavallini, D Lucci, G Musumeci, R Caporale, ... European Heart Journal: Acute Cardiovascular Care 4 (5), 441-452, 2015 | 113 | 2015 |
Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? SD Rosa, P Cirillo, A Paglia, L Sasso, VD Palma, M Chiariello Current vascular pharmacology 8 (2), 259-275, 2010 | 110 | 2010 |